Synthesis of 4-substituted 2H-naphth[1,2-b]-1,4-oxazines, a new class of dopamine agonists

Authors:
  • JJJames H. Jones
    James H. Jones
  • PAPaul S. Anderson
    Paul S. Anderson
  • JBJohn J. Baldwin
    John J. Baldwin
  • BCBradley V. Clineschmidt
    Bradley V. Clineschmidt
  • DMDavid E. McClure
    David E. McClure
  • GLGeorge F. Lundell
    George F. Lundell
  • WRWilliam C. Randall
    William C. Randall
  • GMGregory E. Martin
    Gregory E. Martin

Abstract
A series of tricyclic oxazines, namely, the 4-substituted 2H-naphth[1,2-b]-1,4-oxazines, have been synthesized and assayed for dopamine agonist activity. One of the members of this series, compound (+)VII-15, was found to be a remarkably potent agonist in vivo when tested in the standard 6-hydroxydopamine lesioned rat assay. The absolute configuration of the compound corresponds to that found in the active isomer of apomorphine. Its activity at the alpha 2 receptor (vs. [3H]clonidine) is relatively low. It also failed to stimulate the synthesis of cAMP in the carp retina assay, thus giving the compound a highly selective profile in favor of the D2 receptor.